BioCatalystWatch
HALOWorkspace / HALO / OverviewCompany library
HALOZYME THERAPEUTICS, INC. logo

HALOZYME THERAPEUTICS, INC.

HALOZYME THERAPEUTICS, INC. (HALO)

Website

Price
Market cap
Next catalystExpected 2026Elektrofi / Hypercon technology · Trial initiationCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Other pipelines

PreINDP1P2P3FilingApproved
Upcoming / outlook

PreINDP1P2P3FilingApproved

CD73

PreINDP1P2P3FilingApproved
nivolumab using ENHANZE

PreINDP1P2P3FilingApproved
nivolumab plus relatlimab with ENHANZE®

PreINDP1P2P3FilingApproved

Partner / License out

Approved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

CD38

Approved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

CD38

Approved

PreINDP1P2P3FilingApproved

Approved / commercial

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PD-1

Approved

PreINDP1P2P3FilingApproved

PD-1

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Amyloid-β oligomers

PreINDP1P2P3FilingApproved

programmed death 1

PreINDP1P2P3FilingApproved

programmed death 1

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

HALO PR & News

PR & News

HALO SEC archive